Register (In-Person or Virtual!) • Schedule • Posters • Engage/Mentoring • Students • Destination • Supporters

Pharmacogenomics for Depression: What We Know and What is Needed

Registration Options

Activity Dates: 04/25/2022 - 04/25/2025

Sign in (or create a FREE account) to register or access your existing registrations

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

There is growing focus on use of pharmacogenomic (PGx) testing in the practice of medicine and pharmacy. One company website suggests sales of over 1,500,000 tests. The value it offers within psychiatry remains unclear in certain regards. Current guidelines offer recommendations when PGx results are available but does not provide advice on when or to whom testing may be beneficial. There is also an abundance of PGx testing options available with substantial heterogeneity in terms of clinical validity and utility. In this session, participants will explore different opinions on when to consider ordering PGx testing, what and how to test, as well as strengths and limitations on published clinical studies of PGx guided medication treatment for major depressive disorder.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information

Christina Aquilante, PharmD, FCCP

View biographical information

Learning Objectives

  1. Recognize strengths and limitations of published clinical studies of pharmacogenomic (PGx) guided medication treatment of major depressive disorder (MDD).
  2. Describe considerations for when or whether PGx testing is warranted.
  3. Review the advantages and disadvantages of using multi-gene compared to single-gene PGx testing panels.
  4. Illustrate how to effectively integrate clinical PGx test results into the electronic health record to maximize use of the information for MDD.

Continuing Education Credit and Disclosures

Activity Dates: 04/25/2022 - 04/25/2025
ACPE Contact Hours: 1
ACPE Number: 0284-0000-22-038-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.